Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 16466303)

1.

Long-term adaptive changes induced by serotonergic antidepressant drugs.

Faure C, Mnie-Filali O, Haddjeri N.

Expert Rev Neurother. 2006 Feb;6(2):235-45. Review.

PMID:
16466303
2.

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.

Blier P, de Montigny C.

Biol Psychiatry. 1998 Sep 1;44(5):313-23. Review.

PMID:
9755353
3.

5-HT7 receptor antagonists as a new class of antidepressants.

Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N.

Drug News Perspect. 2007 Dec;20(10):613-8. doi: 10.1358/dnp.2007.20.10.1181354. Review.

PMID:
18301795
4.

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.

Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Review.

PMID:
18761360
5.
6.

Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

Ogren SO, Kuteeva E, Hökfelt T, Kehr J.

CNS Drugs. 2006;20(8):633-54. Review.

PMID:
16863269
7.

Antidepressants and neuroplasticity.

D'Sa C, Duman RS.

Bipolar Disord. 2002 Jun;4(3):183-94. Review.

PMID:
12180273
8.

Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.

Blier P, de Montigny C, Chaput Y.

J Clin Psychopharmacol. 1987 Dec;7(6 Suppl):24S-35S. Review.

PMID:
3323264
9.

Strategies for producing faster acting antidepressants.

Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F.

Drug Discov Today. 2005 Apr 15;10(8):578-85. Review.

PMID:
15837601
10.

Alterations of neuroplasticity in depression: the hippocampus and beyond.

Fuchs E, Czéh B, Kole MH, Michaelis T, Lucassen PJ.

Eur Neuropsychopharmacol. 2004 Dec;14 Suppl 5:S481-90. Review.

PMID:
15550346
11.

Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects.

Mahar I, Bambico FR, Mechawar N, Nobrega JN.

Neurosci Biobehav Rev. 2014 Jan;38:173-92. doi: 10.1016/j.neubiorev.2013.11.009. Epub 2013 Dec 1. Review.

PMID:
24300695
12.

Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication.

Pilar-Cuéllar F, Vidal R, Díaz A, Castro E, dos Anjos S, Pascual-Brazo J, Linge R, Vargas V, Blanco H, Martínez-Villayandre B, Pazos Á, Valdizán EM.

Neural Plast. 2013;2013:537265. doi: 10.1155/2013/537265. Epub 2013 Jun 19. Review.

13.

Does neurotropin-3 have a therapeutic implication in major depression?

Pae CU, Marks DM, Han C, Patkar AA, Steffens D.

Int J Neurosci. 2008 Nov;118(11):1515-22. doi: 10.1080/00207450802174589. Review.

PMID:
18853330
14.

[Depression and neuroplasticity: implication of serotoninergic systems].

Daszuta A, Ban M Sr, Soumier A, Hery M, Mocaer E.

Therapie. 2005 Sep-Oct;60(5):461-8. Review. French.

PMID:
16433011
15.

[ECT: from neuronal plasticity to mechanisms underlying antidepressant medication effect].

Holtzmann J, Polosan M, Baro P, Bougerol T.

Encephale. 2007 Sep;33(4 Pt 1):572-8. Review. French.

PMID:
18033145
16.

R-citalopram prevents the neuronal adaptive changes induced by escitalopram.

Mnie-Filali O, Faure C, Mansari ME, Lambás-Señas L, Bérod A, Zimmer L, Sánchez C, Haddjeri N.

Neuroreport. 2007 Oct 8;18(15):1553-6.

PMID:
17885600
17.

Sexual side effects of antidepressant drugs.

Gelenberg AJ, Delgado P, Nurnberg HG.

Curr Psychiatry Rep. 2000 Jun;2(3):223-7. Review.

PMID:
11122960
18.

[Use of models for spontaneous paroxysmal activity in studies of adaptive changes in serotonin receptors].

Bobula B, Zahorodna A, Tokarski K, Hess G.

Postepy Hig Med Dosw. 2002;56(3):377-83. Review. Polish.

PMID:
12194250
19.

Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.

Blier P, Abbott FV.

J Psychiatry Neurosci. 2001 Jan;26(1):37-43. Review.

20.

Endocannabinoids in the treatment of mood disorders: evidence from animal models.

Bambico FR, Duranti A, Tontini A, Tarzia G, Gobbi G.

Curr Pharm Des. 2009;15(14):1623-46. Review.

PMID:
19442178
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk